Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Accured Expenses (2016 - 2026)

Seres Therapeutics (MCRB) has disclosed Change in Accured Expenses for 11 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 66.19% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.5 million through Dec 2025, up 36.17% year-over-year, with the annual reading at -$6.5 million for FY2025, 36.17% up from the prior year.
  • Change in Accured Expenses hit -$2.3 million in Q4 2025 for Seres Therapeutics, down from $633000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $38.6 million in Q3 2021 to a low of -$19.0 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $2.3 million across 5 years, with a median of -$143500.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: surged 6495.04% in 2023 and later crashed 756.87% in 2024.
  • Year by year, Change in Accured Expenses stood at $65000.0 in 2021, then skyrocketed by 520.0% to $403000.0 in 2022, then soared by 6495.04% to $26.6 million in 2023, then tumbled by 126.12% to -$6.9 million in 2024, then soared by 66.19% to -$2.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for MCRB at -$2.3 million in Q4 2025, $633000.0 in Q3 2025, and -$352000.0 in Q2 2025.